Status: Recruiting
Opt-IVF for Personalized Medicine for Normal Responders
A clinical trial will determine the effectiveness of the Opt-IVF decision-support tool in generating personalized, optimal drug-dosage profiles for each patient in the United States.
Participants needed: 100
Trial details
Phase: Phase 1, Phase 2Age: 20-50Biological sex: FemaleType: InterventionalSponsor: Urmila DIwekarUpdated: Oct 2, 2026Locations: 1
Eligibility criteria
PCOS and Poor Responders